RT Journal Article
SR Electronic
T1 Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e006837
DO 10.1136/jitc-2023-006837
VO 11
IS 9
A1 Ploeg, Emily Maria
A1 Samplonius, Douwe Freerk
A1 Xiong, Xiao
A1 Ke, Xiurong
A1 Hendriks, Mark Alexander Johannes Martinus
A1 Britsch, Isabel
A1 van Wijngaarden, Anne Paulien
A1 Zhang, Hao
A1 Helfrich, Wijnand
YR 2023
UL http://jitc.bmj.com/content/11/9/e006837.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.